IHM
Iguana Healthcare Management Portfolio holdings
AUM
$133M
This Quarter Return
+7.86%
1 Year Return
+45.66%
3 Year Return
+127.07%
5 Year Return
–
10 Year Return
–
AUM
$133M
AUM Growth
+$133M
(-12%)
Cap. Flow
-$18M
Cap. Flow
% of AUM
-13.5%
Top 10 Holdings %
Top 10 Hldgs %
36.02%
Holding
84
New
22
Increased
15
Reduced
14
Closed
22
Top Buys
| 1 |
SHPG
Shire pic
SHPG
|
$3.74M |
| 2 |
Centene
CNC
|
$3.21M |
| 3 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$3.07M |
| 4 |
Labcorp
LH
|
$2.83M |
| 5 |
DexCom
DXCM
|
$2.6M |
Top Sells
| 1 |
CELG
Celgene Corp
CELG
|
$7.83M |
| 2 |
AERI
Aerie Pharmaceuticals, Inc.
AERI
|
$5.08M |
| 3 |
AbbVie
ABBV
|
$4.84M |
| 4 |
Esperion Therapeutics
ESPR
|
$4.7M |
| 5 |
KTWO
K2M Group Holdings, Inc
KTWO
|
$2.84M |
Sector Composition
| 1 | Healthcare | 89.09% |
| 2 | Energy | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Rocket Pharmaceuticals
RCKT
$359M
| $2.34M | 1.54% |
+125,000
| New | +$2.34M |
|
|
MDCO
27
DELISTED
Medicines Co
MDCO
| $2.31M | 1.52% |
70,000
+10,000
| +17% | +$329K |
|
|
ARMO
28
DELISTED
ARMO BioSciences, Inc. Common Stock
ARMO
| $2.25M | 1.48% |
+60,000
| New | +$2.25M |
|
|
SRRA
29
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
| $2.07M | 1.36% |
1,000,000
+200,000
| +25% | +$414K |
|
|
DPLO
30
DELISTED
DIPLOMAT PHARMACY, INC.
DPLO
| $2.02M | 1.33% |
100,000
+50,000
| +100% | +$1.01M |
|
|
MYOK
31
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| $1.95M | 1.28% |
40,000
-10,000
| -20% | -$488K |
|
32
CytomX Therapeutics
CTMX
$341M
| $1.85M | 1.22% |
65,000
-10,000
| -13% | -$284K |
|
33
Iovance Biotherapeutics
IOVA
$836M
| $1.69M | 1.11% |
+100,000
| New | +$1.69M |
|
|
MRTX
34
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $1.69M | 1.11% |
+55,000
| New | +$1.69M |
|
35
Karyopharm Therapeutics
KPTI
$60.9M
| $1.68M | 1.1% |
125,000
-175,000
| -58% | -$2.35M |
|
36
Viking Therapeutics
VKTX
$3.03B
| $1.64M | 1.08% |
375,000
+150,000
| +67% | +$656K |
|
37
Arrowhead Research
ARWR
$3.26B
| $1.44M | 0.95% |
+200,000
| New | +$1.44M |
|
38
Merus
MRUS
$5.01B
| $1.39M | 0.91% |
75,000
-25,000
| -25% | -$463K |
|
39
Voyager Therapeutics
VYGR
$192M
| $1.32M | 0.87% |
70,000
+20,000
| +40% | +$376K |
|
|
AKAO
40
DELISTED
Achaogen, Inc.
AKAO
| $1.3M | 0.85% |
100,000
+25,000
| +33% | +$324K |
|
|
CORI
41
DELISTED
Corium International, Inc.
CORI
| $1.26M | 0.83% |
110,000
+20,000
| +22% | +$229K |
|
42
Incyte
INCY
$16.9B
| $1.25M | 0.82% |
15,000
+5,000
| +50% | +$417K |
|
|
CTLT
43
DELISTED
CATALENT, INC.
CTLT
| $1.23M | 0.81% |
30,000
| – | – |
|
44
Adverum Biotechnologies
ADVM
$63.4M
| $1.16M | 0.76% |
200,000
| – | – |
|
|
CERN
45
DELISTED
Cerner Corp
CERN
| $1.16M | 0.76% |
+20,000
| New | +$1.16M |
|
46
Xencor
XNCR
$598M
| $1.05M | 0.69% |
+35,000
| New | +$1.05M |
|
47
Kura Oncology
KURA
$708M
| $938K | 0.62% |
+50,000
| New | +$938K |
|
|
SGEN
48
DELISTED
Seagen Inc. Common Stock
SGEN
| $916K | 0.6% |
+17,500
| New | +$916K |
|
|
SPPI
49
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
| $805K | 0.53% |
+50,000
| New | +$805K |
|
|
DERM
50
DELISTED
Dermira, Inc.
DERM
| $799K | 0.53% |
100,000
| – | – |
|